Arbitrage Radar

Catalyst Intel: Governor Newsom has publicly stated his opposition to the "billionaire tax," which is a significant negative catalyst. A governor's opposition can heavily influence public opinion and mobilize resources against a ballot initiative. Additionally, the news indicates that tech giants are spending heavily to influence California politics, suggesting strong financial opposition is likely for such a tax.

Legal Reasoning: Market A resolves to 'Yes' if a specific ballot initiative is certified by June 25, 2026, for the November 3, 2026 California election. Market B resolves to 'Yes' if such an initiative 'passes' voter approval. For Market B to resolve to 'Yes', the initiative must first be certified and appear on the ballot. Market A imposes a stricter, earlier deadline (June 25, 2026) for this certification compared to the implicit requirements for Market B. If an initiative is certified after June 25, 2026, but still makes it onto the November 3, 2026 ballot and passes voter approval, Market B would resolve to 'Yes' while Market A would resolve to 'No'. This scenario indicates that Market A's conditions are stricter or have an earlier deadline for a prerequisite event compared to Market B's resolution condition, fitting the definition of A_SUBSET_OF_B, despite the parenthetical clause in the definition not being strictly met due to the possibility of certification by June 25 but failure to pass voter approval.

Catalyst Intel: Multiple news snippets indicate strong pressure from former President Donald Trump and his allies to weaken or eliminate the filibuster. Phrases like 'pressures GOP to scrap filibuster,' 'eye nuking it,' and 'threatens to end filibuster' demonstrate a clear intent and active push to remove this procedural obstacle, particularly to pass legislation like the SAVE America Act. Given Trump's potential influence and the explicit desire to change the filibuster, this constitutes a massive catalyst for it to be weakened before 2027.

Legal Reasoning: Market A requires a specific event: a cloture motion passing with fewer than three-fifths of Senators on a legislative matter. For such a motion to pass, the filibuster threshold must first have been lowered for the legislative process. Market B is broader, resolving to "Yes" if the filibuster threshold is lowered in any capacity (e.g., for legislative matters, confirmations, or both) and does not require an instance of a cloture motion passing. If Market A resolves "Yes," it inherently means the filibuster threshold was lowered, making Market B also resolve "Yes." However, Market B could resolve "Yes" without Market A resolving "Yes" if: 1) the threshold is lowered only for confirmations (which Market A explicitly excludes), or 2) the threshold is lowered for legislative matters, but no actual cloture motion passes under the new threshold before the deadline. Therefore, Market A's conditions are stricter than Market B's.

Catalyst Intel: Multiple news snippets indicate a strong likelihood of several high-profile companies, particularly in the AI sector, going public before 2027. OpenAI is strongly hinted for a 2026 IPO, supported by SoftBank's $40B loan maturing in March 2027. Anthropic is reported to be preparing for an IPO as early as October this year, with major banks involved. Kailera Therapeutics has already filed for a U.S. IPO. SpaceX is also mentioned with 'IPO buzz'. This collective information points to a significant increase in IPO activity before the 2027 deadline.

Legal Reasoning: Both markets resolve to "Yes" if Anysphere (Cursor) completes an IPO by December 31, 2026. Market A's deadline of "December 31, 2026, 11:59 PM ET" is equivalent to Market B's "before Jan 1, 2027". While Market A explicitly mentions negative resolution for mergers/acquisitions/cessation, it is a standard assumption that an IPO for the named entity would not occur if it were acquired or ceased to exist, meaning Market B would also implicitly resolve "No" in such scenarios. The conditions and timeframes are virtually identical.

Catalyst Intel: Kailera Therapeutics has filed for a U.S. IPO, indicating an imminent public offering well before 2027. Anthropic is reportedly planning an IPO as early as October, with talks already underway with major banks, strongly suggesting an IPO before 2027. OpenAI has strong signals for a 2026 IPO, supported by SoftBank's $40B loan maturing in March 2027, providing flexibility for a listing within that timeframe. Visma, while delayed, is still expected to IPO next year, placing it before 2027. These events collectively represent massive catalysts, confirming that multiple significant companies are on track to IPO before 2027.

Legal Reasoning: Both markets concern an IPO by Databricks with identical deadlines (Market A: 'by December 31, 2026, 11:59 PM ET'; Market B: 'before Jan 1, 2027'). Market B's confirmation source ('Databricks confirms an IPO') is a subset of Market A's ('official company announcements or credible news sources'). In practice, if an IPO occurs and is confirmed by official company announcements or credible news sources, Databricks itself would almost certainly have confirmed it. The 'No' conditions in Market A are standard implicit understandings for IPO markets and do not create a conflict or a scenario where one market resolves 'Yes' and the other 'No' for the same event. Therefore, the conditions and timeframes are virtually identical.

Catalyst Intel: No news was provided to evaluate for a catalyst. Therefore, no catalyst can be identified for the market 'Will GOP Nominee be Ken Paxton AND General Election Winner be Republican for Jan 2027?'.

Legal Reasoning: For Market A to resolve to 'Paxton beats Talarico', Ken Paxton must be the Republican nominee and win the 2026 Texas U.S. Senate election. This outcome directly matches the conditions for Market B to resolve 'Yes' (GOP Nominee: Ken Paxton, General Election Winner: Republican). The timeframe for a 2026 election, including potential run-offs, would typically see the winner determined and called by news sources (Market A's primary resolution method) well before Market B's 'before Jan 2027' deadline. Assuming standard political definitions and avoiding pedantic edge cases, the conditions and timeframes are virtually identical.

Catalyst Intel: The news primarily details a significant legislative push and bans related to prediction markets for congressional staff and officials, with multiple bills and individual office policies being implemented. While some snippets mention an ongoing 'push to ban congressional stock trading' and a state lawmaker's call for a 'Congressional ban on insider trading,' these are not presented as new, massive catalysts compared to the extensive activity reported regarding prediction markets. The overall legislative momentum described is predominantly directed at prediction markets, not specifically a comprehensive congressional stock trading ban.

Legal Reasoning: Both markets resolve to 'Yes' if a law banning sitting members of the US Congress from trading stocks is signed into law by December 31, 2026. The conditions and deadlines are identical.

Catalyst Intel: While there is news indicating strong political opposition and a desire from a former Prime Minister (Bennett) to replace Netanyahu, this represents ongoing political struggle rather than a new, massive, and immediate catalyst for his departure. Netanyahu is also shown actively leading and asserting power. The other news snippets focus on broader conflicts or US politics, not directly on an event that would force Netanyahu out of office before January 1, 2027. Therefore, no massive catalyst is identified.

Legal Reasoning: Both markets resolve to "Yes" if Benjamin Netanyahu announces resignation, steps down, or is removed from the position of Prime Minister of Israel. The deadline for both markets is identical: Market A specifies "by December 31, 2026, 11:59 PM ET", while Market B states "before Jan 1, 2027", which covers the exact same period. The conditions and timeframes are virtually identical, meaning if one market resolves to "Yes", the other will as well, and vice-versa. There are no stricter conditions, earlier deadlines, or conflicting rules that would lead to a different resolution.

Catalyst Intel: Multiple news snippets indicate strong likelihood or confirmed plans for several high-profile companies to IPO before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is reported to be coming as early as October this year, with talks already underway with major banks. OpenAI is hinted at for a 2026 or early 2027 IPO, supported by SoftBank's $40B loan. Visma has delayed its IPO to next year (2025). These collectively represent a significant increase in the probability of multiple companies IPOing within the specified timeframe.

Legal Reasoning: Both markets predict whether Anthropic will complete an Initial Public Offering (IPO) by the end of 2026. Market A explicitly states 'completes an Initial Public Offering (IPO)', while Market B states 'Anthropic confirms an IPO'. In the context of prediction markets, 'confirms an IPO' is understood to mean the IPO has completed or is definitively occurring. Therefore, if the IPO 'completes', Anthropic will 'confirm' it, and vice versa. The deadlines are identical ('by December 31, 2026, 11:59 PM ET' is equivalent to 'before Jan 1, 2027'). Market A's resolution sources ('official company announcements or credible news sources') include Anthropic's confirmation. There are no conflicting conditions, definitions, or tie-breakers.

Catalyst Intel: Multiple news snippets confirm that several high-profile companies, including Anthropic, OpenAI, and SpaceX, are planning IPOs well before 2027. Anthropic's IPO is expected as early as October this year, and OpenAI is hinted for 2026. Kailera Therapeutics has filed for a US IPO, and Visma is delaying its IPO to next year (2025). This directly addresses and provides strong evidence for the market 'Who will IPO before 2027?'.

Legal Reasoning: Both markets refer to an IPO by 'Stripe' with identical deadlines ('by December 31, 2026, 11:59 PM ET' is equivalent to 'before Jan 1, 2027'). The condition of 'completes an Initial Public Offering' in Market A and 'confirms an IPO' in Market B are functionally equivalent for market resolution, as an IPO confirmation typically signifies its completion in the context of public trading. Market A's specific 'No' conditions for mergers, acquisitions, or cessation of existence align with implicit 'No' outcomes for Market B, as such events would preclude Stripe from confirming an IPO.

Catalyst Intel: Multiple news snippets confirm that several prominent companies are planning or have filed for IPOs before 2027. Anthropic's IPO is said to be coming as early as October, Kailera Therapeutics has filed for a US IPO, OpenAI is strongly hinted for 2026 or early 2027, SpaceX IPO buzz is present, and Visma is delayed to next year (2025). These events provide strong candidates for the 'Who will IPO before 2027?' market.

Legal Reasoning: Both markets refer to an IPO by OpenAI. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is functionally identical to Market B's "before Jan 1, 2027". Market A's definition of an IPO ("first sale of stock...to the public on any recognized stock exchange") is a standard understanding of an IPO, and Market B's "confirms an IPO" would rely on the same event. Market A's negative conditions (merger, acquisition, cessation of existence) are implicit in Market B as well; if OpenAI doesn't exist, it can't IPO. There are no material differences in conditions or timeframes that would lead to divergent resolutions.

Catalyst Intel: Multiple companies, including Kailera Therapeutics, Anthropic, OpenAI, Visma AS, and SpaceX, show strong indications or have already filed for an IPO before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is reported to be coming as early as October. OpenAI is hinted for a 2026 or early 2027 IPO. Visma AS is delaying its IPO to next year (2025). SpaceX is also mentioned as 'coming soon'. These events collectively represent a significant increase in the likelihood of companies IPOing before 2027.

Legal Reasoning: Both markets resolve to 'Yes' if Deel completes an Initial Public Offering (IPO) by December 31, 2026. Market A specifies 'by December 31, 2026, 11:59 PM ET', while Market B states 'before Jan 1, 2027', which is the exact same timeframe. The resolution sources and definitions of an IPO are also consistent across both markets. If an IPO occurs, both will resolve 'Yes'; if not, both will resolve 'No'.

Catalyst Intel: The news indicates that the implementation of key obligations of the EU AI Act, a significant global AI regulation, could be delayed until 2027 or even 2028. This suggests that comprehensive AI regulation might not be fully in place or effective by 2027, despite ongoing legislative efforts in other regions like the US. This delay acts as a strong signal against the market proposition of significant AI regulation by 2027.

Legal Reasoning: Market A's conditions are stricter and its deadline is earlier than Market B's. Market A requires a bill to include at least one of four specific provisions (prohibition, training restrictions, usage restrictions, human-in-the-loop) and be signed into law by December 31, 2026. Market B is broader, requiring any bill 'regulating AI' to become law by January 1, 2027. If Market A resolves to 'Yes', it means a specific type of AI regulation occurred by an earlier date, which would satisfy Market B's broader condition and later deadline. However, Market B could resolve to 'Yes' if a bill regulating AI (but not necessarily with Market A's specific provisions) becomes law on January 1, 2027, or if a bill regulating AI (but not with Market A's specific provisions) becomes law by December 31, 2026. Thus, if A happens, B must happen, but B can happen without A happening.

Catalyst Intel: Multiple major companies are explicitly mentioned with strong indications of IPOs before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is expected to IPO as early as October (this year). OpenAI is hinted for a 2026 IPO, possibly early 2027, with SoftBank's $40B loan signaling this timeline. Visma has delayed its IPO to next year (2025). SpaceX also has 'IPO buzz' and is mentioned as 'coming soon'. These events directly confirm and accelerate the premise of the market.

Legal Reasoning: Both markets refer to an IPO by Vanta. Market A's deadline is "by December 31, 2026, 11:59 PM ET", which is identical to Market B's "before Jan 1, 2027". The resolution sources and conditions for an IPO confirmation are also functionally equivalent, with Market B's 'confirms an IPO' being covered by Market A's 'official company announcements or credible news sources'. The explicit 'No' conditions in Market A (merger, acquisition, ceases to exist) would implicitly prevent an IPO in Market B, meaning if Market A resolves 'No' for these reasons, Market B would also resolve 'No' because an IPO did not occur.

Catalyst Intel: Multiple news reports indicate SpaceX is preparing for a massive IPO, with some suggesting a filing 'as soon as this week' and a planned raise for 'June 2026.' This strongly suggests SpaceX will IPO before 2027, serving as a significant catalyst for the market.

Legal Reasoning: Both markets require Discord to complete an Initial Public Offering (IPO) by the same deadline (December 31, 2026, which is equivalent to 'before Jan 1, 2027'). While Market A specifies 'official company announcements or credible news sources' for confirmation and Market B specifies 'Discord confirms an IPO', in the real world, an IPO confirmed by credible sources would inherently involve confirmation from the company itself (e.g., through official filings or announcements). Therefore, the conditions for a 'Yes' resolution are virtually identical, and either trade direction is safe.

Catalyst Intel: Multiple news snippets indicate OpenAI is actively preparing for an IPO. Specifically, 'OpenAI Cleans House Ahead of IPO' suggests strategic streamlining for a public offering. Furthermore, the 'OpenAI ads pilot tops $100 million in annualized revenue in under 2 months' demonstrates significant, rapid financial growth in a high-margin business, which is highly attractive to potential IPO investors and a key step in 'sprucing up their financials ahead of mega-IPOs'. These actions and financial successes are strong indicators that an IPO is on the horizon and likely to occur sooner rather than later.

Legal Reasoning: Both markets are tracking the same event: OpenAI completing an Initial Public Offering (IPO) before January 1, 2027. Market A's definition of an IPO and resolution sources align perfectly with the natural interpretation of Market B's conditions. The specific clause in Market A regarding acquisition by an already public company explicitly states a scenario that would implicitly lead to a 'No' resolution in Market B, as OpenAI itself would not have performed an IPO. Therefore, the conditions and outcomes are virtually identical.

Catalyst Intel: The news explicitly states that current Republican Governor Mike Dunleavy is in his final year of office and is prevented by the Alaska Constitution from running for a third consecutive four-year term. This is a massive catalyst as it fundamentally changes the dynamics of the race, removing the incumbent advantage and creating a wide-open contest for all parties and independent candidates.

Legal Reasoning: Market A resolves to the candidate who wins the 2026 Alaska gubernatorial election. Market B resolves to 'Yes' if Matt Heilala is sworn in as governor. Assuming Matt Heilala is a Republican (as implied by ':: Republican' context), if Matt Heilala is sworn in (Market B 'Yes'), then a Republican (Matt Heilala) must have won the election (Market A's ':: Republican' outcome is met). However, it is possible for a Republican other than Matt Heilala to win the election (Market A's ':: Republican' outcome is met), in which case Matt Heilala would not be sworn in (Market B 'No'). Therefore, Market B's condition (Matt Heilala sworn in) is a stricter, more specific condition than Market A's condition (a Republican wins). The swearing-in event for Market B also typically occurs after the election results are confirmed for Market A.

Catalyst Intel: The news presents a mixed and sometimes conflicting picture regarding 2026 GDP growth forecasts across different regions. While S&P Global has revised India's FY26 growth forecast upwards to 7.6%, Goldman Sachs has simultaneously lowered India's 2026 forecast to 5.9%. Additionally, forecasts for countries like Sweden and Australia have been downgraded, often citing geopolitical conflicts. There is no clear, widespread, and unified shift in expectations that would constitute a massive catalyst for overall GDP growth in 2026.

Legal Reasoning: Market A specifies the exact data source and methodology (BEA Advance Estimate for Q4 2026, seasonally adjusted and annualized GDP growth rate for full year 2026) for the condition 'GDP growth in 2026 below 0.0'. Market B uses a more general phrasing 'GDP growth in 2026 below 0.0'. Assuming standard definitions for economic data, Market B implicitly refers to the same official metric specified by Market A. Therefore, the conditions and resolution criteria are virtually identical.

Catalyst Intel: The news indicates multiple high-profile companies are either filing for an IPO, planning one as early as October, or are strongly rumored to go public well before 2027. Kailera Therapeutics has filed for a US IPO. Anthropic is expected to IPO as early as October. OpenAI is strongly linked to a 2026 or early 2027 IPO, with SoftBank's $40B loan pointing to a 2026 listing. Visma has delayed its IPO to next year (2025), still before 2027. SpaceX also has 'IPO buzz' and is mentioned as 'coming soon'. This collective information points to a significant number of IPOs occurring before the 2027 deadline.

Legal Reasoning: Both markets resolve to 'Yes' if Rippling completes an IPO by the end of December 31, 2026. Market A specifies the deadline as 'December 31, 2026, 11:59 PM ET', while Market B states 'before Jan 1, 2027', which is functionally equivalent. The definition of IPO and the implicit confirmation mechanisms are also aligned, avoiding any conflicts or subset relationships for practical resolution. The 'No' conditions in Market A (merger, acquisition, cessation) are implicit outcomes for Market B as well, as these events would preclude Rippling from confirming an IPO.

Catalyst Intel: Multiple news snippets indicate that Kailera Therapeutics has filed for an IPO, Anthropic is expected to IPO as early as October (2024), OpenAI is signaling a 2026 or early 2027 IPO, and Visma is delaying its IPO to next year (2025). SpaceX also has 'IPO buzz' and is mentioned as 'coming soon.' These events directly relate to companies IPOing before 2027, confirming a strong catalyst for the market.

Legal Reasoning: Both markets resolve to 'Yes' if Ramp completes an IPO by December 31, 2026. Market A specifies 'completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET', while Market B states 'confirms an IPO before Jan 1, 2027'. These timeframes are identical. The terms 'completes an IPO' and 'confirms an IPO' are considered equivalent in this context, referring to the successful public offering of stock. Market A's explicit 'No' conditions (merger, acquisition, ceases to exist) are implicitly covered in Market B, as an IPO by Ramp would not occur under those circumstances.

Catalyst Intel: Robert F. Kennedy Jr. is facing intense criticism as HHS Secretary for policies that critics claim endanger public health, risk the resurgence of deadly diseases, and could lead vaccine manufacturers to leave the U.S. market. Furthermore, a close ally indicates his 'Make America Healthy Again' movement is being 'sidelined' by the White House on vaccine policy, suggesting significant internal friction. These severe criticisms and policy conflicts create substantial pressure that could lead to his departure from the HHS Secretary role before 2027.

Legal Reasoning: Market B requires Robert F. Kennedy Jr. to leave the specific role of HHS Secretary. Market A is broader, requiring him to leave any role within the Trump Administration. If he leaves as HHS Secretary, he necessarily leaves the Trump Administration. However, he could leave the Trump Administration from a different role (e.g., as an Ambassador or White House staffer), in which case Market A would resolve 'Yes' but Market B would resolve 'No'. The timeframes for both markets are identical ('before 2027' vs. 'by December 31, 2026'). Therefore, Market B's conditions are stricter and a subset of Market A's.